Copy-number analysis and inference of subclonal populations in cancer genomes using Sclust.
Yupeng CunTsun-Po YangViktor AchterUlrich LangMartin PeiferPublished in: Nature protocols (2018)
The genomes of cancer cells constantly change during pathogenesis. This evolutionary process can lead to the emergence of drug-resistant mutations in subclonal populations, which can hinder therapeutic intervention in patients. Data derived from massively parallel sequencing can be used to infer these subclonal populations using tumor-specific point mutations. The accurate determination of copy-number changes and tumor impurity is necessary to reliably infer subclonal populations by mutational clustering. This protocol describes how to use Sclust, a copy-number analysis method with a recently developed mutational clustering approach. In a series of simulations and comparisons with alternative methods, we have previously shown that Sclust accurately determines copy-number states and subclonal populations. Performance tests show that the method is computationally efficient, with copy-number analysis and mutational clustering taking <10 min. Sclust is designed such that even non-experts in computational biology or bioinformatics with basic knowledge of the Linux/Unix command-line syntax should be able to carry out analyses of subclonal populations.
Keyphrases
- copy number
- mitochondrial dna
- genome wide
- drug resistant
- dna methylation
- single cell
- randomized controlled trial
- genetic diversity
- end stage renal disease
- multidrug resistant
- healthcare
- chronic kidney disease
- ejection fraction
- rna seq
- newly diagnosed
- cystic fibrosis
- high resolution
- gene expression
- artificial intelligence
- molecular dynamics
- deep learning
- solid phase extraction
- childhood cancer